No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial.

Purpose: Chronic low-level systemic and adipose tissue inflammation has been identified as a major etiologic factor in many chronic diseases, including hypertension and cardiovascular diseases. Evidence from experimental studies suggests anti-inflammatory effects of dietary flavonols such as quercet...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Nutrition Vol. 56; no. 7; pp. 2265 - 2276
Autores principales: Brüll, Verena, Burak, Constanze, Stoffel-Wagner, Birgit, Wolffram, Siegfried, Nickenig, Georg, Müller, Cornelius, Langguth, Peter, Alteheld, Birgit, Fimmers, Rolf, Stehle, Peter, Egert, Sarah
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Springer Nature Oct2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125186436&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 125186436
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14366207
        CR0
      jtl: European Journal of Nutrition
      issn: 14366207
      maglogo: N
    pubinfo:
      dt: Oct2017
      vid: 56
      iid: 7
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        125186436
        125186436
        125186436
        10.1007/s00394-016-1267-0
        125186436
      ppf: 2265
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial.
      aug:
        au:
          Brüll, Verena
          Burak, Constanze
          Stoffel-Wagner, Birgit
          Wolffram, Siegfried
          Nickenig, Georg
          Müller, Cornelius
          Langguth, Peter
          Alteheld, Birgit
          Fimmers, Rolf
          Stehle, Peter
          Egert, Sarah
        affil: Department of Nutrition and Food Sciences, Nutritional Physiology , University of Bonn , Endenicher Allee 11-13 53115 Bonn Germany
      sug:
        subj:
          Obesity
          Prehypertension
          Quercetin Administration and Dosage
          Leptin Blood
          Adiponectin Blood
          Inflammation
          Blood Glucose
          Insulin Blood
          Human
          Randomized Controlled Trials
          Random Assignment
          Double-Blind Studies
          Crossover Design
          Dietary Supplementation
          Onions
          Plant Extracts
          Biological Markers Blood
      ab: Purpose: Chronic low-level systemic and adipose tissue inflammation has been identified as a major etiologic factor in many chronic diseases, including hypertension and cardiovascular diseases. Evidence from experimental studies suggests anti-inflammatory effects of dietary flavonols such as quercetin. Methods: We investigated the effects of regular intake of quercetin on leptin, adiponectin, biomarkers of inflammation, glucose and insulin in overweight-to-obese patients with pre- and stage 1 hypertension. Another objective was to assess the safety of daily quercetin supplementation measured by parameters of liver and kidney function and of hematology. Subjects ( n = 70) were randomized to receive a supra-nutritional dose of 162 mg/d quercetin or placebo in a double-blinded, placebo-controlled crossover trial with 6-week treatment periods separated by a 6-week washout period. Two subjects dropped out for personal reasons. Only data from the remaining 68 subjects were included in the analysis. Results: Compared to placebo, quercetin did not significantly affect serum concentrations of leptin and adiponectin, HOMA-AD or the ratios of leptin/adiponectin and adiponectin/leptin. Neither quercetin nor placebo significantly changed serum C-reactive protein and plasma tumor necrosis factor alpha. Compared to placebo, quercetin did not significantly affect glucose, insulin, HOMA-IR, blood biomarkers of liver and renal function, hematology and serum electrolytes. Conclusion: A supra-nutritional dose of 162 mg/d quercetin from onion skin extract for 6 weeks is safe but without significant effects on parameters of systemic and adipose tissue inflammation as well as glucose and insulin in overweight-to-obese subjects with (pre-)hypertension. This trial was registered at and as DRKS00000555.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N